Armata Pharmaceuticals Inc banner
A

Armata Pharmaceuticals Inc
AMEX:ARMP

Watchlist Manager
Armata Pharmaceuticals Inc
AMEX:ARMP
Watchlist
Price: 8.59 USD 2.63%
Market Cap: $312.8m

Wall Street
Price Targets

ARMP Price Targets Summary
Armata Pharmaceuticals Inc

Wall Street analysts forecast ARMP stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ARMP is 15.3 USD with a low forecast of 15.15 USD and a high forecast of 15.75 USD.

Lowest
Price Target
15.15 USD
76% Upside
Average
Price Target
15.3 USD
78% Upside
Highest
Price Target
15.75 USD
83% Upside
Armata Pharmaceuticals Inc Competitors:
Price Targets
VERK
Verkkokauppa.com Oyj
48% Upside
PTGX
Protagonist Therapeutics Inc
15% Upside
SSRM
SSR Mining Inc
53% Upside

Revenue
Forecast

19% / Year
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss
19% / Year
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss

For the last 12 years the compound annual growth rate for Armata Pharmaceuticals Inc's revenue is 19%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-6%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-96%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-96%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ARMP's stock price target?
Price Target
15.3 USD

According to Wall Street analysts, the average 1-year price target for ARMP is 15.3 USD with a low forecast of 15.15 USD and a high forecast of 15.75 USD.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett